Sydney A. Gilman - 28 Jul 2021 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Reporting relationship: VP, Regulatory Affairs
Issuer ticker: DMAC
Reported as of: 28 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jul 2021, 21:18:27 UTC
Source filing: View source filing
Reporting owner signature: /s/ Amy Culbert, attorney-in-fact

Key filing fact

Sydney A. Gilman filed Form 4 for DiaMedica Therapeutics Inc. (DMAC) on 29 Jul 2021.

Key facts

This page summarizes Sydney A. Gilman's Form 4 filing for DiaMedica Therapeutics Inc. (DMAC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Jul 2021, 21:18.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DMAC holding

Voting Common Shares, no par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 28 Jul 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DMAC transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 28 Jul 2021
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 25,000
Exercise price: $5.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Vests in sixteen nearly equal quarterly installments over four years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .